Journal
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY
Volume 62, Issue 1, Pages 3-9Publisher
KOREAN NEUROSURGICAL SOC
DOI: 10.3340/jkns.2018.0151
Keywords
Aspirin; Clopidogrel; Platelet aggregation inhibitors; Platelet function tests
Categories
Funding
- Hallym University Research Fund [HURF-2017-21]
Ask authors/readers for more resources
As more intracranial aneurysms and other cerebrovascular pathologies are treated with neurointervention procedure, thromboembolic events that frequently lead to serious neurological deficit or fatal outcomes are increasing. In order to prevent the thromboembolic events, antiplatelet therapy is used in most procedures including coil embolization, stenting, and flow diversion. However, because of variable individual pharmacodynamics responses to antiplatelet drugs, especially clopidogrel, it is difficult for clinicians to select the adequate antiplatelet regimen and its optimal dose. This article reviews the neurointervention literature related to antiplatelet therapy and suggests a strategy for tailoring antiplatelet therapy in individual patients undergoing neurointervention based on the results of platelet function testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available